Zuyue Wang

zuyue wangZuyue Wang, MD, is a cardiologist and director of Structural and Interventional Echocardiography at MedStar Washington Hospital Center (MWHC). She also serves as a faculty member in the echocardiography laboratory and coronary intensive-care unit at MWHC.

Dr. Wang participates as a co-investigator, specializing in echocardiography, in multiple clinical trials focused on percutaneous aortic valve replacement and mitral valve repair. In addition to her clinical responsibilities, she oversees education of the cardiology fellows in the echocardiography laboratory. She has twice been the recipient of a Joseph Lindsay Teaching Award bestowed by the MWHC cardiology fellows in recognition of her outstanding commitment to education and service in cardiology.

Dr. Wang is frequently invited to speak at national and international meetings. Her research has been published in peer-reviewed journals, including the Journal of the American College of Cardiology, Journal of the American Society of Echocardiography and the American Journal of Cardiology.

She is a fellow of the American College of Cardiology and of the American Society of Echocardiography (ASE), and she is a council member on ASE’s education committee. In addition, she is the director of the Capital Area Echocardiography Society. Dr. Wang is certified by the American Board of Cardiology and the National Board of Echocardiography.

Her medical degree is from the Shanghai Medical College/Fudan University, and she completed a cardiology fellowship at the Shanghai Institute of Cardiovascular Diseases, World Health Organization Collaborating Center for Research and Training in Cardiovascular Diseases at Zhongshan Hospital, Shanghai Medical University. She then completed a residency and fellowship in cardiovascular diseases at Georgetown University/MWHC.

Research Interests

Dr. Wang’s research interests include

  • Valvular heart disease
  • Transesophageal echocardiography (TEE)-guided surgical and interventional procedures for valvular heart disease
  • Hypertrophic cardiomyopathy
  • Percutaneous left atrial appendage occlusion
  • Left ventricular assist device placement
  • Critical care cardiology
  • Three-dimensional echocardiography
  • Contrast echocardiography
  • Aortic pathology.

Selected Research

Placement of Aortic Transcatheter Valve (PARTNER) Trial

Dr. Wang is a co-principal investigator on this trial sponsored by Edwards Lifesciences. This study is being conducted to determine the safety and effectiveness of the heart valve and delivery systems (transfemoral and transapical) in high risk, symptomatic patients with severe aortic stenosis.

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT Trial)

Dr. Wang also is a co-principal investigator on this phase 3 randomized controlled trial sponsored by Evalve/Abbott Vascular. This study is designed to confirm the safety and effectiveness of the MitraClip transcatheter mitral valve repair system for treatment of patients with symptomatic heart failure with moderate-to-severe or severe functional mitral regurgitation.

View Dr. Wang’s publications on PubMed.

  • Research Areas
  • Cardiovascular